Scinovo is the name of our preclinical development offering external companies access to our global expertise in all aspects of preclinical science and drug development.
The Scinovo team brings together the excellent preclinical development science available within GSK with our global network of preferred research suppliers to forge customised drug development solutions for each of our portfolio partners.
Ultimately, we believe this will help ensure faster and more effective development of new medicines for patients.
For more information, visit the Scinovo website.
Building the best product pipeline in the industry
Find out more about our pipeline